Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients
Steven A. Rosenberg+6 more
openalex +2 more sources
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. [PDF]
Yuman Fong+9 more
openalex +1 more source
Extracellular matrix remodeling is crucial in cancer progression. Using a peptide to probe the tension of ECM fibers, it was found that Fibronectin fibers gradually lose tension as human breast carcinoma progresses, while their tension is maintained in ductal carcinoma in situ (DCIS), the non‐invasive precursor of breast cancer. This loss of tension is
Arnaud Miéville+6 more
wiley +1 more source
Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes. [PDF]
Donata Vercelli+5 more
openalex +1 more source
Bilirubin Targeting WNK1 to Alleviate NLRP3‐Mediated Neuroinflammation
At physiological concentrations, bilirubin binds to the kinase domain of WNK1, thereby augmenting its activity and facilitating the phosphorylation of downstream SPAK/OSR1. This phosphorylation inhibits KCC2 activity, leading to elevate intracellular chloride levels in neurons.
Linfei Mao+14 more
wiley +1 more source
Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia. [PDF]
David Peace, Martin A. Cheever
openalex +1 more source
sEVs have a critical role in orchestrating interorgan crosstalk and mediating exercise‐induced therapeutic effects. Lin et al. demonstrates that sEVs miR‐17/20a‐5p mediates the muscle‐brain crosstalk and emphasizes the central role of mTOR signaling in executing molecular programs that can protect brain health in response to exercise. Abstract Physical
Huawei Lin+21 more
wiley +1 more source
Exploring the causal relationship between interleukin levels and osteoarthritis: A two-sample Mendelian randomization analysis. [PDF]
Wu Z, Zhou H, Wu Z, Hou Z.
europepmc +1 more source
Efficacy of interleukin-1 beta against systemic Candida albicans infections in normal and immunosuppressed mice [PDF]
R A Pecyk+2 more
openalex +1 more source